Results 321 to 330 of about 174,618 (333)
Some of the next articles are maybe not open access.
Neuroprotection by tetracyclines
Trends in Pharmacological Sciences, 2004The neuroprotective properties of tetracyclines have been clearly established in rodent models of acute and chronic neurodegeneration during the past few years. Recent findings have provided novel insights into the molecular and cellular mechanisms of protection of neurons and oligodendrocytes by tetracyclines.
Carlos Matute, María Domercq
openaire +3 more sources
2003
The activation of adenosine A1, A2 andA3 receptors can protect neurones against damage generated by mechanical or hypoxic/ischaemic insults as well as excitotoxins. A1 receptors are probably effective by suppressing transmitter release and producing neuronal hyperpolarisation.
openaire +3 more sources
The activation of adenosine A1, A2 andA3 receptors can protect neurones against damage generated by mechanical or hypoxic/ischaemic insults as well as excitotoxins. A1 receptors are probably effective by suppressing transmitter release and producing neuronal hyperpolarisation.
openaire +3 more sources
Strategies for Neuroprotection
Journal of Glaucoma, 2001While glaucoma may be a better candidate for the implementation of neuroprotective strategies than more acute CNS diseases, the failure of clinical neuroprotective trials in stroke should prompt both clinical and basic researchers studying glaucoma to develop better methods to test these agents in animal models, as well as improve methods to quantify ...
openaire +3 more sources
2004
During the last years it has become obvious that the current way of treating epilepsy with antiepeileptic drugs is insufficient concerning the modification of the underlying disesease and provides merely a symptomatic treatment, without clear influence on the course of the disease.
Péter Halász, György Rásonyi
openaire +2 more sources
During the last years it has become obvious that the current way of treating epilepsy with antiepeileptic drugs is insufficient concerning the modification of the underlying disesease and provides merely a symptomatic treatment, without clear influence on the course of the disease.
Péter Halász, György Rásonyi
openaire +2 more sources
Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies
Current Opinion in Ophthalmology, 2003Efforts to discover modalities and pathophysiologies that might afford successful neurorescue, neurorestoration, and neuroprotection of cells of the central nervous system have focused on processes that affect the central nervous system proper, that is, the brain. Often overlooked in the search for neural protection is the fact that the mammalian optic
Barrett Katz +2 more
openaire +3 more sources
Phytoestrogens as neuroprotectants
Drugs of Today, 2009Recent large clinical trials demonstrating deleterious effects of postmenopausal hormone replacement therapy have raised interest in the use of food products and extracts containing phytoestrogens as potential safe alternatives for menopausal symptoms, age-related cognitive decline and neurodegenerative diseases.
openaire +3 more sources
Epilepsia, 2007
Summary Neuroprotection following status epilepticus should encompass not only the prevention of neuronal death, but also preservation of neuronal and network function. This is critical because these aims are not necessarily equivalent; prevention of neuronal loss, for example, does not inevitably prevent epileptogenesis.
openaire +3 more sources
Summary Neuroprotection following status epilepticus should encompass not only the prevention of neuronal death, but also preservation of neuronal and network function. This is critical because these aims are not necessarily equivalent; prevention of neuronal loss, for example, does not inevitably prevent epileptogenesis.
openaire +3 more sources
Australian & New Zealand Journal of Psychiatry, 2011
The case described by Dhillon and colleagues [1] underlines the importance of noting significant clinical events in single case studies as well as providing very important information about the imp...
openaire +3 more sources
The case described by Dhillon and colleagues [1] underlines the importance of noting significant clinical events in single case studies as well as providing very important information about the imp...
openaire +3 more sources
Excitotoxicity and Neuroprotection
The Journal of Clinical Psychiatry, 1997Issue: Excitatory neurotransmission is a normal physiologic process mediated by the neurotransmitter glutamate. Too much glutamate release can be destructive and literally excite a neuron to death in a process called excitotoxicity. Blocking this process may be neuroprotective and prevent brain disorders mediated by excitotoxicity.
openaire +3 more sources